Raspollini MR - Search Results

1

News in the classification of WHO 2022 bladder tumors.

Raspollini MR, Comperat EM, Lopez-Beltran A, Montironi R, Cimadamore A, Tsuzuki T, Netto GJ. Raspollini MR, et al. Pathologica. 2022 Feb;115(1):32-40. doi: 10.32074/1591-951X-838. Epub 2023 Jan 25. Pathologica. 2022. PMID: 36704871 Free PMC article. Review.

2

[Metastatic brain tumors].

Taddei GL, Moncini D, Raspollini MR, Mennonna P, Boddi V, Dini M, Buccoliero AM. Taddei GL, et al. Among authors: raspollini mr. Pathologica. 1999 Feb;91(1):13-7. Pathologica. 1999. PMID: 10396945 Italian.

3

Mucinous Adenocarcinoma of the Male Urethra: A Report of Two Cases.

Raspollini MR, Carini M, Montironi R, Cheng L, Lopez-Beltran A. Raspollini MR, et al. Anal Quant Cytopathol Histpathol. 2015 Aug;37(4):267-72. Anal Quant Cytopathol Histpathol. 2015. PMID: 26410973

4

Unlike in clear cell renal cell carcinoma, KRAS is not mutated in multilocular cystic clear cell renal cell neoplasm of low potential.

Raspollini MR, Castiglione F, Martignoni G, Cheng L, Montironi R, Lopez-Beltran A. Raspollini MR, et al. Virchows Arch. 2015 Dec;467(6):687-693. doi: 10.1007/s00428-015-1859-8. Epub 2015 Oct 5. Virchows Arch. 2015. PMID: 26438300

5

SMARCB1/INI1 Genetic Alterations in Renal Medullary Carcinomas.

Lopez-Beltran A, Cheng L, Raspollini MR, Montironi R. Lopez-Beltran A, et al. Among authors: raspollini mr. Eur Urol. 2016 Jun;69(6):1062-4. doi: 10.1016/j.eururo.2016.01.002. Epub 2016 Jan 15. Eur Urol. 2016. PMID: 26782348 No abstract available.

6

FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence.

Blanca A, Requena MJ, Alvarez J, Cheng L, Montironi R, Raspollini MR, Reymundo C, Lopez-Beltran A. Blanca A, et al. Among authors: raspollini mr. Biomark Med. 2016;10(3):243-53. doi: 10.2217/bmm.15.120. Epub 2016 Feb 9. Biomark Med. 2016. PMID: 26861974

7

Synchronous clear cell renal cell carcinoma and multilocular cystic renal cell neoplasia of low malignant potential: A clinico-pathologic and molecular study.

Raspollini MR, Castiglione F, Cheng L, Montironi R, Lopez-Beltran A. Raspollini MR, et al. Pathol Res Pract. 2016 May;212(5):471-4. doi: 10.1016/j.prp.2016.01.001. Epub 2016 Jan 6. Pathol Res Pract. 2016. PMID: 26874573

8

Genetic mutations in accordance with a low malignant potential tumour are not demonstrated in clear cell papillary renal cell carcinoma.

Raspollini MR, Castiglione F, Cheng L, Montironi R, Lopez-Beltran A. Raspollini MR, et al. J Clin Pathol. 2016 Jun;69(6):547-50. doi: 10.1136/jclinpath-2015-203565. Epub 2016 Mar 3. J Clin Pathol. 2016. PMID: 26941183

9

Multiple and bilateral kidney tumors with clear cells of three different histotypes: A case report with clinicopathologic and molecular study.

Raspollini MR, Castiglione F, Martignoni G, Lapini A, Cheng L, Montironi R, Lopez-Beltran A. Raspollini MR, et al. APMIS. 2016 Jul;124(7):619-623. doi: 10.1111/apm.12536. Epub 2016 Apr 7. APMIS. 2016. PMID: 27061669

10

Genitourinary cancers: molecular determinants for personalized therapies.

Mazzucchelli R, Gasparrini S, Galosi AB, Massari F, Raspollini MR, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R. Mazzucchelli R, et al. Among authors: raspollini mr. Urologia. 2016 Sep 26;83(3):107-109. doi: 10.5301/uro.5000187. Epub 2016 Jun 23. Urologia. 2016. PMID: 27338983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

170 results

Search Page